SLNO icon

Soleno Therapeutics

12 hedge funds and large institutions have $15.9M invested in Soleno Therapeutics in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 8 closing their positions.

Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
6
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
VC
1
Vivo Capital
California
$7.26M 4,033,534 -10,661,730 -73%
OIM
2
Oracle Investment Management
Connecticut
$4.3M 2,388,060 +2,388,060 New
SM
3
Sabby Management
Florida
$1.65M 915,100 +915,100 New
6CM
4
683 Capital Management
New York
$1.52M 844,112 +694,112 +463%
BC
5
Birchview Capital
Vermont
$1.03M 678,428 +678,428 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$73K 40,484 -161,943 -80%
TSS
7
Two Sigma Securities
New York
$39K 21,484 -22,746 -51%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$29K 16,195 +16,195 New
BlackRock
9
BlackRock
New York
$28K 15,600 -62,395 -80%
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$2K 900 +900 New
Deutsche Bank
11
Deutsche Bank
Germany
-601,423 Closed
PAI
12
Palo Alto Investors
California
-84,748 Closed
VF
13
Virtu Financial
New York
-52,942 Closed
Citadel Advisors
14
Citadel Advisors
Florida
-27,368 Closed
Renaissance Technologies
15
Renaissance Technologies
New York
-26,570 Closed
UBS Group
16
UBS Group
Switzerland
-16,718 Closed
Northern Trust
17
Northern Trust
Illinois
-14,376 Closed
Goldman Sachs
18
Goldman Sachs
New York
-10,170 Closed
Morgan Stanley
19
Morgan Stanley
New York
$0 145 -939 -87%
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$0 1 -6 -86%